Stericycle (SRCL)
(Delayed Data from NSDQ)
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
Why Is Waste Connections (WCN) Down 2.6% Since Last Earnings Report?
by Zacks Equity Research
Waste Connections (WCN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Stericycle (SRCL) Stock for Now
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle (SRCL) Gains 3.3% Despite Missing Q2 Estimates
by Zacks Equity Research
Stericycle (SRCL) evidences year-over-year decreases in revenues and earnings in the second quarter of 2023.
Compared to Estimates, Stericycle (SRCL) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Stericycle (SRCL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stericycle (SRCL) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of -12.24% and 2.09%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Analysts Believe Stericycle (SRCL) Could Rally 25.4%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Stericycle (SRCL) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
SRCL or WCN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SRCL vs. WCN: Which Stock Is the Better Value Option?
Stericycle (SRCL) Gains 9% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.
Here's Why You Should Hold Stericycle (SRCL) Stock for Now
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle (SRCL) Gains From Acquisitions Despite Forex Woes
by Zacks Equity Research
Stericycle (SRCL) is benefiting from its multi-year business initiative amid a highly competitive market.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle's (SRCL) Q1 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Stericycle's (SRCL) first-quarter 2023 revenues increase year over year.
Stericycle (SRCL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 13.95% and 1.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stericycle (SRCL) Stock Drops 3% Since Q4 Earnings Release
by Zacks Equity Research
Stericycle's (SRCL) fourth-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 0% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Gains 19% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is currently benefiting from its comprehensive multiyear Business Transformation as well as solid liquidity.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is being aided by a complete multiyear Business Transformation and a solid cash position.
Stericycle (SRCL) Stock Rises 6.6% Since Q3 Earnings Beat
by Zacks Equity Research
Stericycle's (SRCL) third-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 10.17% and 2.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GFL Environmental Inc. (GFL) Q3 Earnings Meet Estimates
by Zacks Equity Research
GFL Environmental Inc. (GFL) delivered earnings and revenue surprises of 0% and 11.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
QRHC or SRCL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?